2018-03-29 09:03 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […]
2018-03-28 09:00 Notice of Annual General Meeting in OrganoClick AB The shareholders of OrganoClick AB (publ), 556704-6908, are hereby convened to the Annual General Meeting (AGM) on Thursday […]
2018-03-27 14:44 Episurf Medical's CEO Pål Ryfors converts A-shares into B-shares Episurf Medical’s CEO Pål Ryfors has converted 983,607 A-shares into B-shares. The main purpose of the conversion is […]
2018-03-23 09:05 OrganoClick publish its Annual Report 2017 OrganoClick’s Annual Report for 2017 is now available on OrganoClick’s homepage, www.organoclick.com. Shareholders and other can receive a […]
2018-03-16 12:00 Xbrane Biopharma AB: Notice of extra general meeting in Xbrane Biopharma AB The shareholders of Xbrane Biopharma AB, reg. no. 556749-2375, (the “Company”), are hereby convened to an extra general […]
2018-03-13 15:34 Insider transaction in Episurf Medical Board member Dennis D. Stripe has on 13 March 2018 bought 6,400 shares in Episurf Medical. Dennis D. […]
2018-03-13 09:34 Episurf Medical will exhibit at BASK 2018, held in Leicester, United Kingdom, on March 20-21 Episurf Medical (NASDAQ: EPIS B) will exhibit at BASK 2018, an orthopaedic conference held in Leicester, United Kingdom […]
2018-03-12 10:04 Promising clinical results from use of Episealer® will be presented at the annual meeting of British Association for Surgery of the Knee “Successful clinical results of a focal individualised mini-metal implant for focal cartilage lesions in the knee” by T. […]
2018-03-12 08:40 IRRAS Provides Update on FDA 510(k) Application of IRRAflow™ – Requests for certain technical clarifications and labeling definition – – Financial targets remain unchanged – San Diego, […]
2018-03-09 14:19 OrganoWood AS enters distribution agreement with Alanor OrganoClick’s subsidiary OrganoWood has signed a general agreement with Alanor AS. The agreement regards sales and distribution of […]
2018-03-09 08:53 OrganoWood AS signs general agreement with Løvenskiold Handel AS/Maxbo, Norway OrganoClick’s subsidiary OrganoWood has signed a general agreement with Maxbo regarding the sales of OrganoWood® modified wood in […]
2018-03-05 17:29 Notice of Annual General Meeting of Episurf Medical AB (publ) The shareholders in Episurf Medical AB (publ), 556767-0541 (“Episurf” or the “Company”), are hereby summoned to the Annual […]
2018-03-05 10:11 IRRAS Appoints Will Martin as Chief Commercial Officer -Mr. Martin will Lead Global Commercial Operations to Grow IRRAflow™ Product Pipeline- San Diego, CA, USA, Laichingen, Germany […]
2018-03-01 16:15 Insider transaction in Episurf Medical Board member Laura Shunk has on 28 February 2018 bought additional 5,000 shares in Episurf Medical. Laura Shunk […]
2018-02-28 10:07 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […]
2018-02-28 09:38 Xbrane Biopharma releases year-end report for 2017 Xbrane Biopharma AB’s (publ.) (“Xbrane”) year-end report for 2017 is now available on the Company’s website, www.xbrane.com. Financial […]
2018-02-28 09:30 IRRAS strengthens executive team with appointment of Kellie Fontes as Senior Director of Human Capital San Diego, California, Stockholm, Sweden, February 28, 2018 – IRRAS (NASDAQ STOCKHOLM: IRRAS), a commercial-stage medical technology company […]
2018-02-28 08:17 Insider transaction in Episurf Medical Board member Laura Shunk has on 27 February 2018 bought 5,000 shares in Episurf Medical. Laura Shunk now […]
2018-02-28 08:16 Diamorph: Year end report 2017 Year End Report 2017 Full year Throughout 2017 the Group has been moving forward with its SEK […]
2018-02-27 15:18 Episurf Medical will exhibit at The Brussels Knee Course, held in Brussels, Belgium, on March 10 Episurf Medical (NASDAQ: EPIS B) will exhibit at The Brussels Knee Course, an orthopaedic conference held in Brussels, […]
2018-02-27 15:12 Episurf Medical will exhibit at The Kiel Arthroscopy Course, held in Kiel, Germany, on March 9-10 Episurf Medical (NASDAQ: EPIS B) will exhibit at The Kiel Arthroscopy Course, an orthopaedic conference held in Kiel, […]
2018-02-27 13:21 Episealer® clinical outcome will be presented at the 2018 world congress of the International Cartilage Repair Society (ICRS) in Macau The abstract “Successful clinical results of a focal individualised mini-metal implant for focal cartilage lesions in the knee” […]
2018-02-26 10:23 Insider transaction in Episurf Medical Board member Leif Ryd has on 24 February bought 60,000 shares in Episurf Medical from Serendipity Ixora. Leif […]
2018-02-23 08:35 Episurf Medical: Year-end report 1 October - 31 December 2017 Fourth quarter 2017, compared to 2016, Group Gross order intake amounted to SEK 885,088 (626,306), an increase of […]
2018-02-23 08:25 Episurf Medical presents strategy update, new external financing and long-term operating targets Episurf Medical (NASDAQ: EPIS B) today presents a strategy update, a new financing agreement and long-term operating targets. […]
2018-02-23 08:20 Episurf Medical AB (publ) secures external financing of up to SEK 70 million and will issue free warrants to its existing shareholders Episurf Medical AB (publ) (“Episurf”) has signed an agreement relating to a financing of up to SEK 70 […]
2018-02-14 07:59 Episurf Medical in the final stages of development of an ankle implant With three Episealer® knee implant products currently approved and on the market in Europe, Episurf Medical (NASDAQ: EPIS […]
2018-02-12 12:22 Episurf Medical invites to a presentation of the 2017 results and a business update on February 23, 2018 Episurf Medical (NASDAQ: EPIS B) will presents its 2017 results, a business update and global opportunities on February […]
2018-02-08 10:23 Another patent approval in the US related to Episurf Medical’s 3D-based damage assessment tool Episurf Medical has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The […]
2018-02-06 09:08 Xbrane Biopharma signs license agreement with CR Pharma for Spherotide in China Press release 2018-02-06 Xbrane Biopharma (publ.) (“Xbrane”) and China Resource Pharmaceutical Group Limited (“CR Pharma”) have entered into […]
